Skip to content

Johnson & Johnson JNJ Payment for (Proceeds from) Other Investing Activity

Payment for (Proceeds from) Other Investing Activity at other companies

Abbott logo
AbbottABT
-$34M-467%
Stryker logo
StrykerSYK
-$1M-105%
Boston Scientific logo
Boston ScientificBSX
-$48M-1,500%
Tenet Healthcare logo
Tenet HealthcareTHC
Pfizer logo
PfizerPFE
Merck & Co. logo
Merck & Co.MRK

Other financials

Income statement

See full
Revenue$25.3B+6.6%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.3%
Net income$5.2B-52.4%
EPS (diluted)$2.27-0.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+31.9%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$601.73B+59.4%
Enterprise value$635.03B+50.5%
P/S6.2×+2.0×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp
FCF margin18.5%-4.3pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromOtherInvestingActivities.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's payment for (proceeds from) other investing activity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's payment for (proceeds from) other investing activity?
Johnson & Johnson (JNJ) reported payment for (proceeds from) other investing activity of $54M in Q1 2026.
How has Johnson & Johnson's payment for (proceeds from) other investing activity changed year-over-year?
Johnson & Johnson's payment for (proceeds from) other investing activity increased by 80.0% year-over-year, from $30M to $54M.
What is the long-term trend for Johnson & Johnson's payment for (proceeds from) other investing activity?
Over 4 years (2021 to 2025), Johnson & Johnson's payment for (proceeds from) other investing activity has grown at a -24.9% compound annual growth rate (CAGR), from $508M to $162M.
What does payment for (proceeds from) other investing activity mean?
Net cash flows resulting from investing activities that do not fall under standard categories like securities or loans. This may include investments in joint ventures, real estate, or other non-financial assets. It serves as a catch-all for miscellaneous capital deployment or divestment activities.